J. Berryman

A Phase Ib open label, randomized, safety study of SANGUINATE™ in patients with sickle cell anemia

H. Misra, A. Abuchowski, K. Gálvez, 2016, Revista brasileira de hematologia e hemoterapia.

A Phase I study to determine safety, pharmacokinetics, and pharmacodynamics of ANF-RHO™, a novel PEGylated granulocyte colony-stimulating factor, in healthy volunteers

R. Jubin, H. Misra, A. Abuchowski, 2018, Investigational New Drugs.